SEC Form 4 · accession 0000897069-26-001482
Processa Pharmaceuticals, Inc. · PCSA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patrick Lin
Officer — Chief Business - Strategy Off
Period of report
Jun 30, 2026
Accepted (ET)
Jul 1, 2026 · 4:19 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001533743
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 30, 2026 | P | 2,106 | $1.93 | A | 13,113 | D | |
| Common Stock | holding | — | — | — | 1,740 | I | Lin Family Trust Feb 4, 2024 |
Table II — derivative securities
No Table II lines on this filing.